Content about Atorvastatin

March 14, 2013
Report: Wegmans extends free atorvastatin offer through end of year

Wegmans will be offering the popular cholesterol-lowering drug atorvastatin free of charge through the end of the year, according to a report published by the Philadelphia Inquirer.

February 26, 2013
Greenstone launches authorized generic cholesterol drug

Greenstone has launched an authorized generic version of a drug used to treat cholesterol.

November 27, 2012
Ranbaxy recalls several lots of generic Lipitor

Ranbaxy Labs has recalled more than three dozen lots of its generic version of a cholesterol-lowering statin drug due to the possible presence of foreign particles, the company said.

September 4, 2012
Meijer offers generic Lipitor for free

In what could symbolize the so-called "patent cliff" that an executive from healthcare market research firm IMS Health spoke of at a recent trade show, a regional mass merchandise chain is taking what used to be the world's top-selling drug and giving it away for free.

August 3, 2012
This is the coming of the 'age of generics'

Astrologers would say this is the Age of Pisces, while the Chinese zodiac calls it the Year of the Dragon. For health care, it might be a good time to start calling it the "Great Generic Epoch."

July 18, 2012
Dr. Reddy's launches generic version of Lipitor

Dr. Reddy's Labs has launched a generic version of a popular cholesterol drug.

May 29, 2012
Mylan launches generic Lipitor

Mylan on Tuesday announced that its subsidiary has received final approval from the Food and Drug Administration for its abbreviated new drug application for atorvastatin calcium tablets, a generic version of Pfizer's Lipitor.

May 23, 2012
Pfizer, EatingWell launch Lipitor For You mobile app

Pfizer has partnered with EatingWell magazine to launch the drug maker's Lipitor For You "Recipes 2 Go" mobile application.

May 17, 2012
FDA approves generic versions of Plavix

The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.

May 15, 2012
Reports: Pfizer 'quietly' giving up on Lipitor marketing

Pfizer apparently is relenting on its attempt to drive sales of its top cholesterol drug as several new generic versions look set to enter the market, according to published reports.

April 11, 2012
Reports: Humira to become top-selling drug this year

Move over, Lipitor: There's a new top drug on the market, according to published reports.

April 9, 2012
Pfizer brings Lipitor marketing campaign to Walgreens Chicago flagship store

Drug maker Pfizer is taking a marketing campaign for one of its drugs to Walgreens' Chicago flagship store to raise awareness about high cholesterol and healthy eating, the company said Monday.

March 26, 2012
Suppliers, FDA shine spotlight on switches

The recent Food and Drug Administration public meeting on driving future switch potential by way of the pharmacist and/or health technology sparked some discussion on what’s next.


March 6, 2012
FDA declines to approve Merck cholesterol drug

The Food and Drug Administration is asking for additional data before it approves a new cholesterol drug made by Merck, the drug maker said.

February 28, 2012
Statins could increase blood sugar, cause cognitive problems, FDA says

Drugs widely used to treat cholesterol may cause increases in blood sugar and other symptoms, the Food and Drug Administration said Tuesday.

February 17, 2012
ReportersNotebook — Chain Pharmacy, 2/27/12

The Food and Drug Administration has approved a drug made by Merck for Type 2 diabetes, the drug maker said. Merck announced the approval of Janumet XR (sitagliptin and metformin hydrochloride) extended-release tablets as a once-daily treatment for the disease.


February 15, 2012
Managed care plans prefer generic over branded Lipitor

Managed care and prescription plans are working to switch patients to generic versions of Pfizer's Lipitor despite the drug maker's efforts to reduce costs for the branded version, a new study suggested.

February 3, 2012
New diabetes drug launches show primary care market still strong

For all the fears about the patent cliff, at least one disease state seems to be on the up-and-up in terms of new drug development and new products.

February 2, 2012
Mylan wins tentative approval for generic Lipitor

The Food and Drug Administration has given tentative approval to a generic cholesterol drug made by Mylan, the drug maker said Thursday.

February 1, 2012
Lipitor foreshadows approaching patent cliff for other leading drugs

For the past several years, drug industry experts have spoken in terms of the “patent cliff,” the period when the patents covering several blockbuster drugs are set to expire, thus leaving their manufacturers with a big, gaping hole in their revenues as those drugs face competition from generics.

January 20, 2012
Challenges and opportunities abound as generic wave hits the shore

One analysis report after another seems to confirm that the generic drug market is in for a huge shift as the number of blockbuster drugs losing patent protection is set to dwindle over the next several years. A recent report by Frost & Sullivan seems to confirm that sentiment.

January 20, 2012
Generics face new and long-standing issues

In the Feb. 7, 2011, issue, Drug Store News named three major issues that would define 2011 for the world of generic drugs. Those issues were drug safety, generic user fees and patent settlements.

January 20, 2012
Lipitor’s patent loss signals future for other top drugs

If the patent cliff were a sports team, Pfizer’s cholesterol-
lowering drug Lipitor (atorvastatin) would be its mascot.

January 3, 2012
ReportersNotebook — Chain Pharmacy, 1/9/12

Pharmacy technology provider PDX is partnering with Mscripts to allow existing PDX Classic and Enterprise Pharmacy System customers to add mobile to their customer-facing offerings, the companies said.

December 23, 2011
Thomson Reuters report forecasts post-blockbuster era

Drug makers will focus on patient-specific therapies instead of drugs designed for use by a broad range of people over the next decade, according to a new report released Thursday by Thomson Reuters.

© 2013 Drug Store News. All Rights Reserved.